Norges Bank’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,000
Closed -$311K 2217
2021
Q4
$311K Sell
25,000
-197,400
-89% -$2.46M ﹤0.01% 2171
2021
Q3
$6.95M Buy
222,400
+197,400
+790% +$6.17M ﹤0.01% 1856
2021
Q2
$716K Hold
25,000
﹤0.01% 2140
2021
Q1
$1.08M Buy
25,000
+5,000
+25% +$217K ﹤0.01% 2043
2020
Q4
$1.43M Hold
20,000
﹤0.01% 1989
2020
Q3
$603K Buy
+20,000
New +$603K ﹤0.01% 2069